`gn` is the vector
```
> dput(gn)
c("AID", "AXL", "bcl2", "BCL6", "CD10", "CD103", "CD11c", "CD123", 
"CD137", "CD14", "CD141", "CD16", "CD163", "CD1A", "CD1c", "CD20", 
"CD207", "CD21", "CD23", "CD248", "CD27", "CD3", "CD303", "CD30v", 
"CD31", "CD32abc", "CD34", "CD4", "CD4543", "CD5", "CD56", "CD64", 
"CD68", "CD69", "CD7", "CD74", "CD79a", "CD8", "CD86", "CLEC10A", 
"CLEC9A", "cMAF", "CXCL13a", "EOMES", "FoxP3", "GATA3", "GRB7", 
"HLADR", "ID2", "IDO", "IgD", "IRF4", "IRF8", "KappaS", "Ki67", 
"LAG3", "LambdaS", "LYVE1", "LYZ", "MX1", "MYC", "MYCN", "OX40", 
"Pax5", "PD1", "PDL1", "PNAd", "Podoplanin", "PRDM1", "PU1", 
"RORC", "S100B", "SOX9", "TCF4", "TCF7", "TCRd", "TIM3", "TOX1", 
"vWF", "ZEB1")
```
```
> library(ellmer)
> library(btw)
> ch = chat_ollama(model="gpt-oss:20b")
> ch$chat(btw(gn, "How can the genes in gn be used to characterize spatial substructure of human lymph nodes?"))
```
**Short answer**

The list you’ve shown is a curated “marker bouquet” that can be read by a spatial‑omics pipeline (RNAscope, 
MERFISH, seqFISH, CODEX, Visium, 10× Xenium, etc.) to **paint the classic zones of a human lymph node**:

| Zone | Gene set that lights it up | What it tells you | How to use it in a pipeline |
|------|---------------------------|-------------------|-----------------------------|
| **Follicle / Germinal center (GC)** | **AID, BCL6, CD10, CD21, CD23, CXCL13, GATA3, PU1** | B‑cell activation / somatic hypermutation / centroblasts vs. centrocytes | *Spot‑wise enrichment* of the GC‑gene module → GC map. |
| **Paracortical (T‑cell zone)** | **CD3, CD4, CD8, CCR7, LFA1, PD‑1, LAG3, FoxP3, TOX1, RORC** | Helper / cytotoxic / regulatory T cells, cytokine states | *Co‑expression* of T‑cell modules + FoxP3 → T‑reg enrichment spot. |
| **High Endothelial Venules (HEVs)** | **PNAd, CD34, CD31, VWF** | Vascular entry portal | *Cluster of HEV‑genes* → vascular scaffold. |
| **Stromal / Fibroblastic reticular cells (FRCs)** | **Podoplanin, CXCL12, DPP4, LAMB1, COL1A1** | Reticularmesh, LTB, ECM | *FRC‑module* → medullary/peripheral stroma. |
| **Macrophage / DC** | **CD68, LYZ, CLEC10A, CLEC9A, CD1c, CD207** | Antigen‑presenting / phagocytic | *Spotclusters* identify “macrophage” or “DC” sub‑niches. |
| **Plasma cells / Medullary cords** | **PRDM1, IRF4, CD138 (SLC), Ki67 (proliferative)** | Antibody factories | *PRDM1‑module* → medullary cord spots. |
| **Marginal zone / Sinus** | **CD209, CD68, LYVE1, VWF, CD21** | Sinus macrophages, lymph flow | *Sinus‑genes* map the outermost layers. |

**In practice, the workflow looks like this**

1. **Design / choose your spatial tool**  
   * For a small gene list (~70 genes) you can use multiplexed FISH (MERFISH, seqFISH, RNAscope) or 
mass‑cytometry imaging (CODEX, Imaging Mass Cytometry).  
   * For higher coverage you can do a capture‑based approach (10× Xenium, Visium, Slide‑seq) and then 
*filter* the data to your gene list.

2. **Pre‑processing**  
   ```R
   library(Seurat)
   obj <- CreateSeuratObject(counts = spatial_counts, assay = "Spatial")
   obj <- NormalizeData(obj)
   obj <- FindVariableFeatures(obj, assay = "Spatial")  # will highlight your markers automatically
   ```

3. **Gene‑module construction**  
   * Group the genes into biologically meaningful sets (GC, T‑cell, macrophage, etc.).  
   * For each spot, compute a **module score** (Seurat::AddModuleScore) that sums scaled expression of the 
set of genes.  
   * Optionally perform *principal component analysis* on the module scores to capture gradient effects.

4. **Spatial clustering**  
   * Run a spatially aware clustering algorithm (e.g., `SpatialWNN`, `SpaGCN`, or `stlearn`) that weights 
both transcriptome and location.  
   * Inspect the resulting clusters for enrichment of your modules.

5. **Visualization & validation**  
   * Plot each module on the tissue layout to get a “heat‑map atlas” of LN substructure.  
   * Overlay protein (IHC / IF) or in‑situ hybridization patterns to confirm fidelity.  
   * Quantify spot‑by‑spot differences between patient groups or disease states.

6. **Advanced analyses (optional)**  
   * **Spatially resolved cell‑type deconvolution**: use `cell2location` or `Stereoscope` with your marker 
set to infer cell‐type proportions per spot.  
   * **Signal‑cell communication**: use `NicheNet` or `CellChat` on the same spatial data, using the 
GC/T‑zone modules as ligand/cell signatures.  
   * **Trajectory inference**: apply `Slingshot` or `Monocle3` to the pooled spots of the GC zone to see 
dark‑zone → light‑zone transitions.

---

### Why these genes “light up” the zones

| Gene | Cell‑type / function | Spatial niche |
|------|----------------------|---------------|
| **AID, BCL6** | Somatic hypermutation & GC B‑cell transcription factor | GC light/dark zones |
| **CD10, CD21, CD23, CXCL13** | Follicular dendritic cells & chemokine | Follicular germinal center |
| **CD3, CD4, CD8** | T cell subsets | Paracortex (“T‐cell zone”) |
| **FoxP3, LAG3, PD‑1** | Regulatory / exhausted T cells | Deep T‑zone & interfollicular areas |
| **CD34, CD31, PNAd** | High endothelial venules (HEV) | Entry points on cortical rim |
| **Podoplanin, CXCL12** | FRC and stromal reticular cells | Medullary cords, periphery |
| **CD68, LYZ** | Macrophages | Sinus, medulla |
| **CLEC10A, CLEC9A** | DC subsets | Paracortex, cortex |
| **PRDM1, IRF4** | Plasma cells | Medullary cords |
| **VWF, CD61** | Vascular endothelial & platelet adhesion | Sinusoids & venules |

The **co‑expression patterns** of the above genes are highly predictive of the LN microarchitecture even in a
noisy data set: for example, a spot that is high for *CD3, CD4, CXCR3, CCR7* and *low for AID* is almost 
certainly a **T‑cell cortex** spot. A spot with *AID, BCL6, CD21* would be a **GC centre** spot.

---

### Pitfalls and how to avoid them

| Issue | What can go wrong | How to mitigate |
|-------|------------------|-----------------|
| **Cross‑talk / “spillover”** (adjacent spots share transcripts) | Over‑smoothed boundaries | Use 
high‑resolution platforms (seqFISH, RNAscope) or correct with spatial deconvolution (Stereoscope). |
| **Heterogeneous cell mixtures** | Mixed cell‑type spots blur niche signals | Deconvolve with reference 
scRNA‑seq; restrict to spots with high GC vs. T‑zone scores. |
| **Expression dropout** | Loss of low‑expressed markers | Increase sequencing depth or use targeted panel 
amplification. |
| **Marker overlap** (e.g., CD3 also on NK cells) | Mis‑annotation of cell type | Combine multiple markers 
(CD3+CD56–) and context (high CXCL13 in follicle helps confirm B cell) |
| **Batch effects** | Spurious spatial clusters | Apply integration methods (Harmony, Seurat V3 integration) 
before spatial analysis. |

---

### What you can do next

1. **Generate a “spatial atlas”** – Overlay all five (or six) modules to create a composite map that can be 
compared across patients.  
2. **Quantify zone sizes / ratios** – Compute the fraction of spots per zone; correlate with clinical 
variables (e.g., age, disease severity).  
3. **Disease vs. healthy** – Use the same marker set to see if, e.g., GC size shrinks or T‑reg distribution 
changes in rheumatoid arthritis or lymphoma.  
4. **Cross‑validation** – Perform multiplexed immunohistochemistry (IF) for a small subset of markers, 
confirm the spot‑level pattern, and refine the atlas.  
5. **Integrate with flow cytometry / CyTOF** – Use the same markers to align phenotypic data (e.g., PD‑1+ 
Tregs) with spatial context.

---

### Bottom line

The genes in your list are the “lattice coordinates” of a human lymph node.  By quantifying their expression 
in a spatially resolved manner, you can:

- **Segregate the classic zones** (germinal center, paracortex, medulla, HEVs, sinuses).  
- **Identify functional subtypes** (centroblasts vs. centrocytes, T‑reg vs. effector T cells, stromal vs. 
endothelial cells).  
- **Expose spatial relationships** (e.g., T‑cell exclusion from the GC, proximity of macrophage‑rich 
sinusoids to vascular entry points).  

Once you paint the map, the next step is to interrogate *what’s happening in those locations*—cell‑cell 
communication, cytokine gradients, and ultimately disease pathology.  Use the above workflow, and you’ll go 
from a raw gene list to a high‑resolution “map of life” inside a human lymph node.
